文献速递呼吸危重症与机械通气

低成本开源无创压力支持呼吸机的性能与可行性测试

Low-cost, easy-to-build noninvasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing.
PubMed 文献 · Eur Respir J · 2020-06-04

针对中低收入国家商用呼吸机价格高昂导致可及性差的问题,研究者基于市售材料和Arduino Nano控制器设计了一款总零售成本低于75美元的无创双水平压力呼吸机,并在模拟 obstructive/restrictive 疾病的台架测试及12名健康志愿者中与商用Lumis 150呼吸机进行对比。结果显示原型机可提供吸/呼气压力达20/10 cmH2O,无触发或切换故障,志愿者呼吸困难评分从无支持时的5.45±1.68显著降至2.83±1.66(p<0.005),与商用设备(2.80±1.48;p=1.000)无差异。

要点

  • 开源无创呼吸机成本低于75美元,性能与商用设备相似。
  • 志愿者呼吸困难评分显著改善,与商用设备无差异。
  • 提供开放源代码硬件描述,便于中低收入国家复制使用。

核心结论

  • 低成本易构建的无创呼吸机性能与高质量商用设备相似,开源硬件描述可免费复制并在中低收入国家使用。

研究设计与样本

  • 研究基于市售材料和Arduino Nano控制器构建无创双水平压力呼吸机,总零售成本低于75美元,硬件描述开源。
  • 在模拟阻塞性/限制性疾病的主动呼吸患者模拟器上进行台架测试,并与商用Lumis 150呼吸机比较。
  • 在12名健康志愿者佩戴高气道阻力和胸/腹带以模拟阻塞性/限制性患者条件下进行测试。

主要发现

  • 原型机提供吸气和呼气压力分别高达20/10 cmH2O,台架和志愿者测试中均无触发或切换故障。
  • 负荷呼吸受试者呼吸困难评分(1-10分)从无支持时的5.45±1.68显著降至使用原型机时的2.83±1.66(p<0.005)。
  • 原型机呼吸困难评分与商用设备(2.80±1.48;p=1.000)无差异。

关键数值与推荐

  • 原型机吸/呼气压力可达20/10 cmH2O。
  • 呼吸困难评分改善p<0.005,与商用设备比较p=1.000。

临床怎么用

  • 该开源低成本无创呼吸机可在资源匮乏地区作为商用设备的替代选择,便于本地复制和生产。
  • 适用于需要无创通气的中低收入国家患者,有望扩大救命治疗的可及性。

局限性

  • 测试仅在台架模拟器和12名健康志愿者中进行,未在真实患者中验证。
  • 未报告长期使用效果、安全性及不同疾病人群中的性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Current pricing of commercial mechanical ventilators in low-/middle-income countries (LMICs) markedly restricts their availability, and consequently a considerable number of patients with acute/chronic respiratory failure cannot be adequately treated. Our aim was to design and test an affordable and easy-to-build noninvasive bilevel pressure ventilator to allow a reduction in the serious shortage of ventilators in LMICs. METHODS: The ventilator was built using off-the-shelf materials available via e-commerce and was based on a high-pressure blower, two pressure transducers and an Arduino Nano controller with a digital display (total retail cost <75 USD), with construction details provided open source for free replication. The ventilator was evaluated, and compared with a commercially available device (Lumis 150 ventilator; Resmed, San Diego, CA, USA): 1) in the bench setting using an actively breathing patient simulator mimicking a range of obstructive/restrictive diseases; and b) in 12 healthy volunteers wearing high airway resistance and thoracic/abdominal bands to mimic obstructive/restrictive patients. RESULTS: The designed ventilator provided inspiratory/expiratory pressures up to 20/10 cmH2O, respectively, with no faulty triggering or cycling; both in the bench test and in volunteers. The breathing difficulty score rated (1-10 scale) by the loaded breathing subjects was significantly (p<0.005) decreased from 5.45±1.68 without support to 2.83±1.66 when using the prototype ventilator, which showed no difference with the commercial device (2.80±1.48; p=1.000). CONCLUSION: The low-cost, easy-to-build noninvasive ventilator performs similarly to a high-quality commercial device, with its open-source hardware description, which will allow for free replication and use in LMICs, facilitating application of this life-saving therapy to patients who otherwise could not be treated.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Garmendia O, Rodríguez-Lazaro MA, Otero J, et al. Low-cost, easy-to-build noninvasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing. Eur Respir J. 2020. PMID: 32312862. doi:10.1183/13993003.00846-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。